Influenza News and Research

Latest Influenza News and Research

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

The vaccine rollout was a success. But events within and beyond Biden’s control stymied progress.

Echinacea purpurea may help prevent respiratory tract infections during COVID-19 pandemic

Echinacea purpurea may help prevent respiratory tract infections during COVID-19 pandemic

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Exploring the possibility of developing a plant-based oral vaccine against COVID-19

Effectiveness of inactivating SARS-CoV-2 by spraying disinfectant in the form of Dry Fog

Effectiveness of inactivating SARS-CoV-2 by spraying disinfectant in the form of Dry Fog

Nanotrap particles can improve current sequencing workflows of SARS-CoV-2

Nanotrap particles can improve current sequencing workflows of SARS-CoV-2

Severity of SARS-CoV-2 compared to other human coronaviruses in children

Severity of SARS-CoV-2 compared to other human coronaviruses in children

SARS-CoV-2 transmission through indoor aerosols

SARS-CoV-2 transmission through indoor aerosols

Omicron variant may strike double vaccinated

Omicron variant may strike double vaccinated

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Determination of the effectiveness of COVID-19 vaccination using T cell receptor repertoire

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

Bioinformatics pipeline can be used to quickly identify SARS-CoV-2 therapeutics

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Study suggests pre-existing human common cold coronavirus antibodies hinder SARS-CoV-2 immunity

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Seasonal coronaviruses may help estimate SARS-CoV-2 reinfection risk

Researchers develop a universal SARS-CoV-2 neutralizing antibody

Researchers develop a universal SARS-CoV-2 neutralizing antibody

A pandemic-scale phylogenetic analysis tool

A pandemic-scale phylogenetic analysis tool

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

A new rapid and inexpensive PCR method to detect SARS-CoV-2 Omicron variant

Infant immune system beats the adult immune system at fighting off new pathogens

Infant immune system beats the adult immune system at fighting off new pathogens

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

Nasal vaccine provides broad-based protection against heterologous respiratory viruses in mice

Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2

Maternal and neonatal cord-blood antibody profile in response to SARS-CoV-2

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

Characterization of the baseline SARS-CoV-2 S-reactive B cell repertoire

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.